Search results for "OCT"

showing 10 items of 3052 documents

Predictors of Progression in Hypertensive Renal Disease in Children

2004

In hypertensive renal disease in children, several risk factors influence the development and the rate of progression of renal damage, including blood pressure levels, proteinuria, lipid disorders, and genetic differences. The impact of blood pressure on renal structures, the most important of the factors, depends not only on blood pressure levels, but also on the persistence of the blood pressure levels over time, mainly during the hours when the patient is resting or sleeping. Abnormal circadian variability is frequently observed in patients with renal damage, and nocturnal blood pressure reduction should be a major therapeutic objective to protect against a decline in renal function. Pro…

medicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismRenal functionDiseaseurologic and male genital diseasesRisk FactorsInternal medicineInternal MedicineHumansMedicineIn patientCircadian rhythmChildReview PaperProteinuriabusiness.industryRenal damageAge FactorsPrognosisNocturnal blood pressureProteinuriaBlood pressureEndocrinologyHypertensionDisease ProgressionCardiologyKidney Diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessThe Journal of Clinical Hypertension
researchProduct

DOP41 Efficacy and safety of open-label treatment with tofacitinib 10 mg twice daily in patients with ulcerative colitis with clinical response, but …

2019

medicine.medical_specialtyTofacitinibOctave (poetry)business.industryOPEN LABEL TREATMENTGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisMaintenance therapyInternal medicinemedicineIn patientbusinessJournal of Crohn's and Colitis
researchProduct

Do overactive bladder symptoms and their treatment-associated changes exhibit a normal distribution? Implications for analysis and reporting

2020

Aims: To explore the use of means vs medians (assuming or not the presence of normal distribution) in studies reporting overactive bladder syndrome symptoms and to test for normal distribution of basal values and treatment-associated changes thereof in two large noninterventional studies. Methods: Systematic review of all original studies reporting on at least one overactive bladder syndrome symptom published in four leading urology journals in 2016 to 2017. Testing of the normal distribution of urgency, incontinence, frequency, and nocturia in two large noninterventional studies (n = 1335 and 745). Results: Among 48 eligible articles, 86% reported means (assuming a normal distribution), 6%…

medicine.medical_specialtyUrologyMedizin030232 urology & nephrologyNormal Distribution610 MedizinNormal distribution03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineInternal medicine610 Medical sciencesmedicineNocturiaHumansBaseline values030219 obstetrics & reproductive medicinebusiness.industryUrinary Bladder Overactivemedicine.diseaseOveractive bladder syndrome3. Good healthUrinary IncontinenceOveractive bladderPropiverineNocturiaNeurology (clinical)medicine.symptombusinessmedicine.drug
researchProduct

First meta-analysis of octreotide for variceal bleeding. A lost opportunity

2002

medicine.medical_specialtyVariceal bleedingHepatologybusiness.industryOctreotideEsophageal and Gastric VaricesOctreotideGastroenterologyHemostaticsMeta-Analysis as TopicInternal medicineMeta-analysismedicineHumansGastrointestinal Hemorrhagebusinessmedicine.drugJournal of Hepatology
researchProduct

Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study.

2021

BACKGROUND Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy. AIM To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone. METHODS We conducted a case-control study involving 30 male patients affected by CAF with hypertonic …

medicine.medical_specialtybusiness.industryChronic anal fissureCase-control studyGeneral MedicineCase Control StudyAnoplastyBotulinum toxinSurgeryFissurectomyBotulinum toxinAnal fissure; Anoplasty; Botulinum toxin; Fissurectomy; ProctologymedicineTonicityProctologyAnal fissurebusinessmedicine.drugWorld journal of clinical cases
researchProduct

Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Diabetes

2003

medicine.medical_specialtybusiness.industryGeneral Medicinemedicine.diseaseNocturnal blood pressureBlood pressureInternal medicineDiabetes mellitusAlbuminuriaCardiologyMedicineMicroalbuminuriaCircadian rhythmmedicine.symptombusinessNew England Journal of Medicine
researchProduct

Somatostatin-Rezeptor-Szintigraphie bei endokriner Orbitopathie

1994

Somatostatin receptor scintigraphy with 111In-labeled octreotide proves to be a very sensitive diagnostic tool for evaluation of inflammative activity in endocrine ophthalmopathy (EO). The results of somatostatin receptor scintigraphy (SRS) in 40 patients with EO show a high orbital accumulation of 111In-octreotide in clinically active EO (4 h-median/orbit-brain-ratio: 12.6; controls 4 h-median: 5.8) Patients with clinically inactive EO (4 h-median: 7.1) show a similar orbital accumulation of radioactivity compared to controls. 5 patients with active orbital myositis also revealed an even higher orbital accumulation of radioactivity (4 h-median: 42.3). The diagnostic value of SRS lies in it…

medicine.medical_specialtybusiness.industryGraves' diseaseOctreotidePeptide hormonemedicine.diseaseGastroenterologyeye diseasesEndocrinologySomatostatinOrbital MyositisInternal medicinemedicineRadiology Nuclear Medicine and imagingDifferential diagnosisReceptorbusinessMyositismedicine.drugRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Octreotide prevents the pathological alterations of bowel obstruction in cancer patients

1996

medicine.medical_specialtybusiness.industryNursing researchPain medicineGeneral surgeryOctreotideCancerOctreotidemedicine.diseaseGastroenterologyIntestinesBowel obstructionGastrointestinal AgentsOncologyNeoplasmsInternal medicinePreoperative CaremedicineHumansbusinessPathologicalIntestinal Obstructionmedicine.drugSupportive Care in Cancer
researchProduct

Sleep–wake problems in patients with amyotrophic lateral sclerosis: implications for patient management

2012

SUMMARY Sleep–wake problems are frequent, although unrecognized, complications of amyotrophic lateral sclerosis (ALS). Sleep disorders such as insomnia, sleep-disordered breathing and restless legs syndrome have all been reported in patients with ALS, despite the limited number of studies and the small populations investigated so far. Sleep disturbances gradually worsen with disease progression, suggesting a relationship between the severity of disease and the neurodegenerative process. However, poor sleep can also be a consequence of several disturbances such as anxiety, depression, pain, choking, sialorrhea, fasciculations, cramps, nocturia and the inability to get comfortable and move f…

medicine.medical_specialtybusiness.industrymedicine.diseasePhysical medicine and rehabilitationExcessive daytime somnolencemedicineInsomniaNocturiaAnxietyNeurology (clinical)Restless legs syndromemedicine.symptomAmyotrophic lateral sclerosisChokingbusinessDepression (differential diagnoses)Neurodegenerative Disease Management
researchProduct

Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C

2021

Mariasanta Napolitano,1 Arne Agerlin Olsen,2 Anne Mette Nøhr,2 Hermann Eichler3 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo Reference Regional Center for Thrombosis and Hemostasis, Hematology Unit, Palermo, Italy; 2Novo Nordisk A/S, Biopharm Manufacturing Development, Gentofte, Denmark; 3Saarland University and Saarland University Hospital, Institute of Clinical Haemostaseology and Transfusion Medicine, Homburg (Saar), GermanyCorrespondence: Anne Mette NøhrBiopharm Manufacturing Development, Novo Nordisk A/S, Nybrovej 80, Gentofte 2820, DenmarkTel +45 3075 1619Email amnq@novonordisk.…

medicine.medical_specialtybusiness.industryturoctocog alfa pegolHematologyTuroctocog alfa030204 cardiovascular system & hematologyGastroenterologyJournal of Blood Medicine03 medical and health sciences0302 clinical medicinetemperature stabilityfactor VIII030220 oncology & carcinogenesisAmbient humidityInternal medicinehemic and lymphatic diseasesmedicinePotencyfactor VIII hemophilia A storage flexibility temperature stability turoctocog alfa turoctocog alfa pegolhemophilia Astorage flexibilityturoctocog alfabusinessHot and humidOriginal ResearchJournal of Blood Medicine
researchProduct